| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in MIRM over the last quarter tilts toward selling: insiders offloaded a net 68,132 shares worth roughly $7.2M. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), MIRM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 108.5K | $10.91M | - | |
| CFO | 47.2K | $4.74M | - | |
| COO | 40.3K | $4.05M | - | |
| Other | 18.9K | $1.90M | - | |
| Dir | 3.8K | $379.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Peetz Christopher45 | Chief Executive Officer | Sell | 5,159 | $20.62 | $106,390.45 | -5.3% | +24.7% | +39.4% | |
| Jan 9, 2023 | Longpre Lara | Chief Development Officer | Sell | 1,003 | $20.62 | $20,684.17 | -1.0% | +24.7% | +39.4% | |
| Nov 15, 2022 | O'Donnell Niall | Director | Sell | 300,000 | $19.86 | $5,956,855.05 | -5.6% | +17.5% | +51.6% | |
| Jun 6, 2022 | Flynn James E62 | 10% Owner, * Possible Member Of 10% Group | Sell | 38,478 | $25.01 | $962,255.52 | -0.4% | +3.7% | +14.6% | |
| Nov 26, 2021 | Clements Ian63 | Chief Financial Officer | Buy | 1,450 | $14.14 | $20,505.00 | +4.2% | +74.6% | +48.2% | |
| Nov 24, 2021 | Peetz Christopher45 | President And CEO | Buy | 7,000 | $14.40 | $100,800.00 | +33.3% | +64.1% | +38.8% | |
| Oct 1, 2021 | Clements Ian63 | Chief Financial Officer | Sell | 1,574 | $19.26 | $30,308.94 | -8.6% | -18.8% | +8.6% | |
| Oct 1, 2021 | Peetz Christopher45 | President And CEO | Sell | 3,672 | $19.26 | $70,708.03 | -14.9% | -18.8% | +8.6% | |
| Oct 1, 2021 | Vig Pamela | Chief Scientific Officer | Sell | 1,364 | $19.26 | $26,264.91 | -12.4% | -18.8% | +8.6% | |
| Oct 1, 2021 | Longpre Lara | Chief Development Officer | Sell | 961 | $19.26 | $18,505.02 | -1.1% | -18.8% | +8.6% |